Two New Drugs Help Relieve Sickle-Cell Disease. But Who Will Pay?

Adakveo and Oxbryta could be revolutionary treatments, but each costs about $100,000 per year and must be taken for life.

from NYT > Health https://ift.tt/2OYDvfs
via health&fitness